Covance Is Now Labcorp Drug Development

We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.

Learn More


Top Five Models for Immuno-Oncology Studies

Scientists at Labcorp have run close to 1,000 preclinical immuno-oncology studies over the past five years. While new models continue to be developed, our scientists have found the following to be their commonly used "workhorse" models, time-tested and optimized for evaluating a wide range of therapeutic approaches. The following models are quite diverse, offering not only several histotypes for test agent development, but also the range of capabilities offered at Labcorp by which these models can be supported.